133 related articles for article (PubMed ID: 2483427)
1. In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells.
Baudin B; Drouet L
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S37-42. PubMed ID: 2483427
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
[TBL] [Abstract][Full Text] [Related]
4. Direct effects of the angiotensin-converting enzyme inhibitor ramiprilat on adult rat ventricular cardiomyocytes.
Helmig S; Schuckenböhmer P; Heger J; Euler G; Piper HM; Schlüter KD
Acta Physiol (Oxf); 2007 Dec; 191(4):267-74. PubMed ID: 17825088
[TBL] [Abstract][Full Text] [Related]
5. High-affinity binding of the converting enzyme inhibitor, ramiprilat, to isolated human glomeruli.
Becker RH; Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S31-4. PubMed ID: 2474098
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Busse R; Fleming I; Hecker M
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
10. [3H]ramiprilat binding to the angiotensin-converting enzyme in rat renal brush-border membranes: the effect of chloride.
Grima M; Mosser J; Welsch C; Barthelmebs M; Imbs JL
Eur J Pharmacol; 1991 Mar; 206(3):203-9. PubMed ID: 1649762
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitor effect on bradykinin metabolism in the vascular wall.
Gohlke P; Bünning P; Bönner G; Unger T
Agents Actions Suppl; 1992; 38 ( Pt 3)():178-85. PubMed ID: 1462857
[TBL] [Abstract][Full Text] [Related]
12. High affinity binding of ramiprilat on isolated human glomeruli.
Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
Biochem Pharmacol; 1988 Dec; 37(24):4679-84. PubMed ID: 2849453
[TBL] [Abstract][Full Text] [Related]
13. Kinetic properties of the angiotensin converting enzyme inhibitor ramiprilat.
Bünning P
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S31-5. PubMed ID: 2485060
[TBL] [Abstract][Full Text] [Related]
14. Assay of tissue angiotensin converting enzyme.
Welsch C; Grima M; Giesen EM; Helwig JJ; Barthelmebs M; Coquard C; Imbs JL
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S26-31. PubMed ID: 2483425
[TBL] [Abstract][Full Text] [Related]
15. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells.
Kohlstedt K; Busse R; Fleming I
Hypertension; 2005 Jan; 45(1):126-32. PubMed ID: 15569856
[TBL] [Abstract][Full Text] [Related]
16. Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.
Gillis CN; Chen X; Merker MM
J Pharmacol Exp Ther; 1992 Jul; 262(1):212-6. PubMed ID: 1320684
[TBL] [Abstract][Full Text] [Related]
17. Evidence for stimulation of neutrophil degranulation by selected angiotensin converting enzyme inhibitors in vitro.
Miselis J; Siminiak T; Wysocki H
J Hum Hypertens; 1994 Aug; 8(8):565-9. PubMed ID: 7990082
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
[TBL] [Abstract][Full Text] [Related]
19. Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins.
Chen K; Zimmerman BG
J Pharmacol Exp Ther; 1994 Aug; 270(2):491-7. PubMed ID: 8071842
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
Hecker M; Bara AT; Busse R
Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
